GH-secreting tumors are largely sporadic, but genetic abnormalities in the X chromosome (X-linked acrogigantism), overexpression of the pituitary tumor transforming gene (PTTG), and mutations in the aryl hydrocarbon receptor-interacting protein (AIP) have been discovered.